Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast

Código QR

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast

Stephan Forchhammer, Kamran GhoreschiDepartment of Dermatology, University Medical Center, Eberhard Karls University of Tübingen, Tübingen, GermanyAbstract: Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis (PsO). The treatment of PsA can be challengi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Forchhammer S, Ghoreschi K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/c8a288be468e4a1189948c2772423669
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
por: Chiricozzi A, et al.
Publicado: (2019)

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
por: Kingsley GH, et al.
Publicado: (2015)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
por: Rajagopalan M, et al.
Publicado: (2021)

Plaque psoriasis in children and adolescents &ndash; the role of etanercept
por: Ricceri F, et al.
Publicado: (2012)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021)

Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
por: Zoe Apalla, et al.
Publicado: (2019)

A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report
por: Rowawi R, et al.
Publicado: (2020)

Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options
por: Haroon M, et al.
Publicado: (2013)

Local effects of adipose tissue in psoriasis and psoriatic arthritis
por: Kruglikov IL, et al.
Publicado: (2017)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi A, et al.
Publicado: (2019)

Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014)

Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population
por: Cassia FF, et al.
Publicado: (2021)

Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis
por: Molteni S, et al.
Publicado: (2012)

Epidemiology and treatment of psoriasis: a Brazilian perspective
por: Duarte GV, et al.
Publicado: (2015)

Epidemiology and treatment of psoriasis: a Chinese perspective
por: Pan R, et al.
Publicado: (2014)

Long-term safety of biologics in the treatment of psoriasis
por: Panchal MR, et al.
Publicado: (2013)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
por: Birgit Sadoghi, et al.
Publicado: (2021)

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
por: Zarema R. Khismatullina, et al.
Publicado: (2021)

Psoriasis in childhood: effective strategies to improve treatment adherence
por: Shah KN, et al.
Publicado: (2015)

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
por: Levy LL, et al.
Publicado: (2012)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014)

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik B, et al.
Publicado: (2016)

Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy
por: Flatz L, et al.
Publicado: (2013)

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
por: Yélamos O, et al.
Publicado: (2015)

Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
por: Rogalski C
Publicado: (2015)

Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity
por: Zhuolin Guo, et al.
Publicado: (2022)

CD8αα+T cells exert a pro‐inflammatory role in patients with psoriasis
por: Y. Y. Zhang, et al.
Publicado: (2021)

Quality of life in patients with psoriatic arthritis
por: Kseniya Mikhailovna Koreshkova, et al.
Publicado: (2021)

Genetic markers for psoriatic arthritis in patients with psoriasis. Part I: non-HLA genes
por: Alexey A. Kubanov, et al.
Publicado: (2021)

Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
por: Noisette A, et al.
Publicado: (2018)

Hidradenitis supurativa tratada con apremilast: serie de casos
por: P. Garbayo-Salmons, et al.
Publicado: (2021)

Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016)

Psoriasis in pregnancy: challenges and solutions
por: Vena GA, et al.
Publicado: (2015)

Self-management in patients with psoriasis
por: Pathak SN, et al.
Publicado: (2014)

The management of psoriasis through diet
por: Duarte G, et al.
Publicado: (2012)

Lipid profile in psoriasis patients
por: Bhat RM, et al.
Publicado: (2012)

Fumaric acid esters in the management of psoriasis
por: Balak DMW
Publicado: (2015)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
por: Ly K, et al.
Publicado: (2019)

Optimal management of nail disease in patients with psoriasis
por: Piraccini BM, et al.
Publicado: (2015)

Links and risks associated with psoriasis and metabolic syndrome
por: Liakou AI, et al.
Publicado: (2015)